Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of everolimus (RAD001) in progressive or metastatic bone and soft tissue sarcomas
2007-005294-60Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in bone cancer, soft tissue sarcoma (STS), Bone and soft tissue sarcoma, alveolar soft part sarcoma (ASPS), sponsored by Novartis. Started Jan 2008; status: completed.
02
Drugs
everolimus
03
Conditions
bone cancersoft tissue sarcoma (STS)Bone and soft tissue sarcomaalveolar soft part sarcoma (ASPS)
Beyond the preview
Go deeper on 2007-005294-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005294-60.